Neurocrine Biosciences
NBIX
#1338
Rank
C$23.59 B
Marketcap
C$233.11
Share price
-1.90%
Change (1 day)
15.57%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2026 (TTM): C$1.20 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are C$3.70 Billion. In 2025 the company made an earning of C$1.00 Billion, an increase over its 2024 earnings that were of C$0.87 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$1.20 B20.15%
2025 C$1.00 B14.74%
2024 C$0.87 B96.41%
2023 C$0.44 B41.13%
2022 C$0.31 B73.74%
2021 C$0.18 B-8.82%
2020 C$0.19 B77.78%
2019 C$0.11 B49.83%
2018 C$75 M-142.57%
2017 -C$0.18 Billion-14.73%
2016 -C$0.21 Billion53.15%
2015 -C$0.14 Billion46.25%
2014 -C$92.25 Million29.66%
2013 -C$71.15 Million-3530.8%
2012 C$2.07 M-95.73%
2011 C$48.58 M
2009 -C$68.3 Million-45.38%
2008 -C$0.13 Billion-58.87%
2007 -C$0.31 Billion87.3%
2006 -C$0.17 Billion351.97%
2005 -C$35.91 Million-52.09%
2004 -C$74.96 Million-10.98%
2003 -C$84.2 Million
2001 -C$62.85 Million
1999 -C$28.35 Million108.32%
1998 -C$13.61 Million
1996 C$4.15 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$9.97 B 707.42%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$18.35 B 1,384.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$49.79 B 3,928.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
C$43.93 M-96.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-C$59.81 Million-104.84%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
C$0.22 B-81.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-C$11.99 Million-100.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
C$2.21 B 78.95%๐Ÿ‡ฌ๐Ÿ‡ง UK